Global Cell Sorting Market - 2023-2030
The Global Cell Sorting Market reached US$ 236.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 389.8 million by 2030. The Global Cell Sorting Market is expected to exhibit a CAGR of 6.6% during the forecast period 2023-2030.
Cell sorting has numerous applications in research, clinical diagnostics, and therapeutics. It makes it possible to separate rare cell groups, including stem cells or circulating tumor cells, for further analysis. Additionally, it makes it easier to purify particular cell types for therapeutic uses like developing cell-based medicines or researching immune cell populations.
However, the high cost of devices, stringent regulations, lack of skilled personnel and lack of awareness of cell sorting technology in developing countries are some factors hindering the growth of the cell sorting market.
Market Dynamics
The Rising Chronic Disease Burden is Boosting the Global Cell Sorting Market Growth During the Forecast Period
Nearly 60% of American adults suffer from at least one chronic illness. The major causes of death in the US include chronic diseases like diabetes, cancer, and cardiovascular disease. Heart disease, cancer, stroke, chronic obstructive pulmonary disease, and diabetes account for over two-thirds of all fatalities.
According to the CDC, 90% of the nation's $3.8 trillion in annual healthcare costs are attributable to persons with chronic illnesses and mental health issues. According to a recent report by the Partnership to Fight Chronic Disease, by 2030, the expense of treating the seven most prevalent chronic diseases in the United States will total $2 trillion annually or $8,600 per person. According to the same report, reducing harmful behaviors might prevent 1,100,000 deaths annually.
The Growing Biopharmaceutical Industry is Boosting the Global Cell Sorting Market Growth During the Forecast Period
One of the largest industries in America is biopharma, which is worth billions of dollars annually and is crucial to the American economy and the patients who use their products. This business is experiencing tremendous expansion due to the emergence of CDMO Biologics companies, which are generating pharmaceuticals more quickly than before.
The expansion of this industry is also attributed to an expanding world population. The demand from the world's population has increased pressure on the biopharma business, but it has also allowed it to attract more investment, increase profitability, and expand.
The Expansion of Personalized Medicine Provides the Global Cell Sorting Market Growth Opportunities
With personalized medicine, it's possible to transform a ""one size fits all"" approach to diagnosis, medication, and prevention into an individualized one. Targeted treatments based on unique patient traits are the goal of personalized medicine. Identifying and isolating particular cell types for customized therapeutics depend heavily on cell sorting technology. The demand for cell sorting technology is anticipated to rise as personalized medicine grows.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a positive impact on the cell sorting market. The variability of the immune response and the effects of COVID-19 on various cell types have been extensively studied using single-cell analytic techniques, including cell sorting. The pandemic has enhanced single-cell analysis techniques and increased demand for cell sorting technology by highlighting the need to comprehend individual cells' traits and reactions.
Russia-Ukraine Conflict Analysis
The impact of the Russia-Ukraine war on the cell sorting market is complex and multifaceted. Resources, attention, and finance for the construction of healthcare infrastructure in the impacted areas may be diverted by the conflict and its aftermath. This might affect how cutting-edge technologies, like cell sorting, are adopted and used in healthcare and research contexts.
Segment Analysis
The Global Cell Sorting Market is segmented based on technology, product and services, application, End-user, and region.
The Fluorescence-Activated Cell Sorting (FACS) Segment is Expected to Hold a Dominant Position in the Market Over the Forecast Period
The fluorescence-activated cell sorting (FACS) segment accounted for the highest market stake, accounting for approximately 43.6% of the cell sorting market in 2022. The flow cytometry technique, fluorescence-activated cell sorting (FACS), is specialized. Using the unique light scattering and fluorescence properties of each cell, it offers a way for dividing a heterogeneous mixture of living cells into two or more containers, one cell at a time.
It is a practical scientific tool since it allows for the quick, accurate, and quantitative recording of fluorescence signals from individual cells as well as the physical segregation of cells of specific interest.
Geographical Analysis
Increasing Collaborations And Product Launches by the Key Players, and Increasing FDA Approvals, Dominate the North American Region
North America is expected to dominate the cell sorting market, accounting for around 39.6%. The market player applies strategies such as product launches and collaboration to expand their business.
For instance, in January 2023, Thermo Fisher Scientific, the leader in serving science, launched the Bigfoot Spectral Cell Sorter in India. The groundbreaking cell sorting system combines spectral sorting and analysis with traditional sorting to produce quick, simple-to-use cell sorting.
Competitive Landscape
The major global players in the market include Bio-Rad Laboratories, Inc., Sony Biotechnology Inc., BD, Merck KGaA, Danaher Corporation, Miltenyi Biotec GmbH, Affymetrix, Inc., Sysmex Partec GmbH, On-Chip Biotechnologies Co., Ltd., Thermo Fisher Scientific among others.
Why Purchase the Report?
• To visualize the Global Cell Sorting Market segmentation based on the technology, product and services, application, End-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of cell sorting market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The Global Cell Sorting Market Report Would Provide Approximately 69 Tables, 70 Figures And 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Technology
- 3.2. Snippet by Product and Services
- 3.3. Snippet by Application
- 3.4. Snippet by End-user
- 3.5. Snippet by Region
- 4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Increasing number of chronic disease testing
- 4.1.2. Restraints
- 4.1.2.1. High costs and services
- 4.1.3. Opportunity
- 4.1.3.1. Technological advancements
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's 5 Forces Analysis
- 5.2. Supply Chain Analysis
- 5.3. Unmet Needs
- 5.4. Regulatory Analysis
- 6. COVID-19 Analysis
- 6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
- 6.2. Pricing Dynamics Amid COVID-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During the Pandemic
- 6.5. Manufacturers’ Strategic Initiatives
- 6.6. Conclusion
- 7. Russia-Ukraine War Analysis
- 8. Artificial Intelligence Analysis
- 9. By Technology
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.1.2. Market Attractiveness Index, By Technology
- 9.2. Fluorescence-activated cell sorting (FACS)*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Magnetic-activated cell sorting (MACS)
- 9.4. Micro-Electromechanical Systems (MEMS) Microfluidics
- 9.5. Density Gradient Centrifugation
- 9.6. Immunodensity Cell Separation
- 9.7. Sedimentation
- 9.8. Others
- 10. By Product and Services
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
- 10.1.2. Market Attractiveness Index, By Product and Services
- 10.2. Cell Sorters*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 10.3. Cell Sorting Reagents & Consumables
- 10.4. Cell Sorting Services
- 11. By Application
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.1.2. Market Attractiveness Index, By Application
- 11.2. Clinical Applications*
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 11.3. Research Applications
- 11.3.1. Immunology & Cancer Research
- 11.3.2. Stem Cell Research
- 11.3.3. Drug Discovery
- 11.3.4. Other Research Applications
- 12. By End user
- 12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
- 12.1.2. Market Attractiveness Index, By End user
- 12.2. Research Institutes*
- 12.2.1. Introduction
- 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 12.3. Pharmaceutical & Biotechnology Companies
- 12.4. Hospitals and Clinical Testing Laboratories
- 12.5. Medical Schools and Academic Institutions
- 13. By Region
- 13.1. Introduction
- 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 13.1.2. Market Attractiveness Index, By Region
- 13.2. North America
- 13.2.1. Introduction
- 13.2.2. Key Region-Specific Dynamics
- 13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
- 13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
- 13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 13.2.7.1. The U.S.
- 13.2.7.2. Canada
- 13.2.7.3. Mexico
- 13.3. Europe
- 13.3.1. Introduction
- 13.3.2. Key Region-Specific Dynamics
- 13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
- 13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
- 13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 13.3.7.1. Germany
- 13.3.7.2. The U.K.
- 13.3.7.3. France
- 13.3.7.4. Italy
- 13.3.7.5. Spain
- 13.3.7.6. Rest of Europe
- 13.4. South America
- 13.4.1. Introduction
- 13.4.2. Key Region-Specific Dynamics
- 13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
- 13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
- 13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 13.4.7.1. Brazil
- 13.4.7.2. Argentina
- 13.4.7.3. Rest of South America
- 13.5. Asia-Pacific
- 13.5.1. Introduction
- 13.5.2. Key Region-Specific Dynamics
- 13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
- 13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
- 13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 13.5.7.1. China
- 13.5.7.2. India
- 13.5.7.3. Japan
- 13.5.7.4. Australia
- 13.5.7.5. Rest of Asia-Pacific
- 13.6. Middle East and Africa
- 13.6.1. Introduction
- 13.6.2. Key Region-Specific Dynamics
- 13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Services
- 13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
- 14. Competitive Landscape
- 14.1. Competitive Scenario
- 14.2. Product Benchmarking
- 14.3. Company Share Analysis
- 14.4. Key Developments and Strategies
- 15. Company Profiles
- 15.1. Bio-Rad Laboratories, Inc.*
- 15.1.1. Company Overview
- 15.1.2. Product Portfolio and Description
- 15.1.3. Financial Overview
- 15.1.4. Key Developments
- 15.2. Sony Biotechnology Inc.
- 15.3. BD
- 15.4. Merck KGaA
- 15.5. Danaher Corporation
- 15.6. Miltenyi Biotec GmbH
- 15.7. Affymetrix, Inc
- 15.8. Sysmex Partec GmbH
- 15.9. On-Chip Biotechnologies Co., Ltd.
- 15.10. Thermo Fisher Scientific
- LIST NOT EXHAUSTIVE
- 16. Appendix
- 16.1. About Us and Services
- 16.2. Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook